Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.43 |
| ▸ | AMY2A | P04746 | 1/20 | 0.41 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | OGA | O60502 | 1/20 | 0.35 |
| ▸ | PYGB | P11216 | 1/20 | 0.35 |
| ▸ | FGF1 | P05230 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15958769 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL19276586 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL19271988 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL17636459 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL18104476 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL19276587 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL17753791 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL17636456 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL19018542 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 | |
| SCHEMBL13647094 | 1.00 | AMY1A (0.43) | AMY1AAMY2ASLC5A2LGALS8STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11191822-B2 | Pneumococcal polysaccharide-protein conjugate composition | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-12-07 | — | — | US | disclosed |
| EP-3900739-A1 | SYNTHETIC STREPTOCOCCUS PNEUMONIAE SACCHARIDE CONJUGATES TO CONSERVED MEMBRANE PROTEIN | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-10-27 | — | — | EP | disclosed |
| US-10864261-B2 | Synthetic vaccines against Streptococcus pneumoniae serotype 2 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-12-15 | — | — | US | disclosed |
| US-20190240309-A1 | PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2019-08-08 | — | — | US | disclosed |
| US-10220083-B2 | Vaccines against Streptococcus pneumoniae serotype 8 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2019-03-05 | — | — | US | disclosed |
| EP-3046587-B1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS (DE) | 2018-01-31 | — | — | EP | disclosed |
| EP-3269385-A1 | PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2018-01-17 | — | — | EP | disclosed |
| US-20170239341-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2017-08-24 | — | — | US | disclosed |
| EP-3000820-A1 | Synthetic vaccines against Streptococcus pneumoniae serotype 8 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-03-30 | — | — | EP | disclosed |
| WO-2015040140-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-26 | — | — | WO | disclosed |
| EP-2851092-A1 | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10220083-B2 | Vaccines against Streptococcus pneumoniae serotype 8 | LGALS8, SIGLEC7, FUT5 | AMY1A 1174/4885AMY2A 1783/4885SLC5A2 899/4885 |
| US-20170239341-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 8 | LGALS8, SIGLEC7, FUT5 | AMY1A 1174/4885AMY2A 1783/4885SLC5A2 899/4885 |
| US-10864261-B2 | Synthetic vaccines against Streptococcus pneumoniae serotype 2 | FUT5, SIGLEC7, ST6GAL1 | AMY1A 1230/4885AMY2A 887/4885SLC5A2 273/4885 |
| US-20190240309-A1 | PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | STT3A, STT3B, DDOST | AMY1A 3707/4885AMY2A 4240/4885SLC5A2 3716/4885 |
| US-11191822-B2 | Pneumococcal polysaccharide-protein conjugate composition | STT3A, STT3B, DDOST | AMY1A 3707/4885AMY2A 4240/4885SLC5A2 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.